Triglyceride-Lowering Drug Gets FDA Nod for Rare Genetic Disorder

(MedPage Today) — The FDA approved plozasiran (Redemplo) for the reduction of triglycerides in people with familial chylomicronemia syndrome (FCS), the agency announced.
The small interfering RNA (siRNA) therapy, designed to reduce triglyceride…